![]() ERD-3111 structure
|
Common Name | ERD-3111 | ||
---|---|---|---|---|
CAS Number | 2832865-25-3 | Molecular Weight | 854.89 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C45H46F4N8O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ERD-3111ERD-3111 (Compound 44) is an orally active PROTAC ERα degrader (DC50: 0.5 nM). ERD-3111 inhibits tumor growth in the parental MCF-7 xenograft model with wild-type ER and two clinically relevant ESR1 mutated mice model. ERD-3111 can be used in the research of ER+ breast cancer[1]. |
Name | ERD-3111 |
---|
Description | ERD-3111 (Compound 44) is an orally active PROTAC ERα degrader (DC50: 0.5 nM). ERD-3111 inhibits tumor growth in the parental MCF-7 xenograft model with wild-type ER and two clinically relevant ESR1 mutated mice model. ERD-3111 can be used in the research of ER+ breast cancer[1]. |
---|---|
Related Catalog | |
Target |
ERα[1] |
References |
Molecular Formula | C45H46F4N8O5 |
---|---|
Molecular Weight | 854.89 |